Last reviewed · How we verify
NCT03951181: LEAP-MS
Life-Style Exercise and Activity Package for People Living With Progressive MS
NA trial testing LEAP-MS in Multiple Sclerosis in 21 participants. Completed in 19 April 2021.
19 April 2021
Quick facts
| Lead sponsor | Cardiff University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 21 |
| Start date | 13 August 2020 |
| Primary completion | 19 April 2021 |
| Estimated completion | 19 April 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- LEAP-MS
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Cardiff University
Who can join
18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators know that many people with multiple sclerosis (MS) require support to remain physically active and often do not receive any or enough support. This is particularly the case for People with Progressive MS (PwPMS) with moderate to severe disability - those who require assistance to mobilise (i.e. using a stick, frame or wheelchair) and/or have other MS related symptoms such as fatigue and difficulties remembering. In Phase 1 of the LEAP-MS study the investigators collected information about the barriers to and facilitators of physical activity (PA) that PwPMS experience, their current levels and type of physical activity and their perceptions of the role physical activity plays in managing MS symptoms from both them and their families - or people that support them. This provided important information about why physical activity might be important for PwPMS, the challenges they face in doing physical activity or accessing it, and ways which they have found to overcome any barriers. The investigators also collected information from physiotherapists and other health care professionals who specialise in treating people with MS, about their understanding of self-management and their needs for training about using self-management approaches with PwPMS. The investigators used this information to co-produce (with the involvement of PwPMS patients and physiotherapists/healthcare professionals) a personalised intervention; Life-style, exercise and activity package for people living with progressive multiple sclerosis (LEAP-MS) to facilitate on-going physical activity for people with PwPMS and a training package about self-management with PwPMS for physiotherapists. In this feasibility study the investigators will evaluate the acceptability of the LEAP-MS intervention. The investigators will also evaluate feasibility of conducting a future trial of the intervention in terms of recruitment, retention, adherence (usage), outcome measures and safety evaluation and establishing fidelity of intervention delivery.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Lifestyle, Exercise and Activity Package for People living with Progressive Multiple Sclerosis (LEAP-MS): adaptions during the COVID-19 pandemic and remote delivery for improved efficiency.
Lowe R, Barlow C, Lloyd B, Latchem-Hastings J, et al · · 2021 · cited 14× · PMID 33863342 · DOI 10.1186/s13063-021-05245-1 -
Web-based physical activity intervention for people with progressive multiple sclerosis: application of consensus-based intervention development guidance.
Busse M, Latchem-Hastings J, Button K, Poile V, et al · · 2021 · cited 8× · PMID 33727274 · DOI 10.1136/bmjopen-2020-045378 -
Lifestyle, exercise and activity package for people living with progressive multiple sclerosis (LEAP-MS): protocol for a single-arm feasibility study.
Latchem-Hastings J, Randell E, Button K, Jones F, et al · · 2021 · cited 5× · PMID 34022955 · DOI 10.1186/s40814-021-00852-w -
Lifestyle, exercise and activity package for people living with progressive multiple sclerosis (LEAP-MS): Protocol for a Single-Arm Feasibility Study.
Latchem-Hastings J, Randell E, Button K, Jones F, et al · · 2020 · DOI 10.21203/rs.3.rs-30578/v1
Verify or expand the search:
- PubMed search for NCT03951181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Cardiff University trials
Trials by the same sponsor.
- NCT06587360 — fertiShare Evaluation · NA · recruiting
- NCT06639867 — Sensor-based Physiotherapy Intervention With Virtual Reality · NA · active not recruiting
- NCT05726669 — Self-help Booklets for Depression in Adults With Pulmonary Hypertension. · NA · completed
- NCT05779527 — Mindful Parenting - A Single Case Experimental Design Study · NA · unknown
- NCT04904523 — Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children. · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03951181 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardiff University
- Last refreshed: 2 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03951181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing